Evidence map›Paper›PMID 42626424›Full record

ArticleFrontiers in neurology2026

Epidemiological investigation and risk factor analysis of acute kidney injury in non-intensive care unit hospitalized patients following neurosurgery.

Yan Xu, Wen Li, Chunling Dong, Aihua Zhang

Abstract read
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yan XuDepartment of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China.
Wen LiDepartment of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China.
Chunling DongSchool of Computer and Cyber Sciences, Communication University of China, Beijing, China.
Aihua ZhangDepartment of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) after neurosurgery is non-negligible. Given brain-kidney crosstalk, postoperative AKI (PO-AKI) can trigger adverse outcomes, but evidence remains limited for neurosurgical patients in non-ICU settings. Methods: Data from non-ICU inpatients undergoing neurosurgical procedures were collected from Xuanwu Hospital, Capital Medical University. We observed PO-AKI incidence and performed category-weighted multiple regression to identify risk factors. Results: Data from 9,692 patients were analyzed, yielding a PO-AKI incidence of 3.9%. Sixteen potential risk variables were identified: male sex or age ≥50 years versus female <50 years; intraoperative/immediate postoperative vasopressor use (OR = 4.129, 95% CI: 3.324-5.129); operation duration ≥120 min (OR = 1.797, 95% CI: 1.597-2.021); contrast agent use (OR = 1.912, 95% CI: 1.674-2.184); BMI category, with BMI < 18.5 kg/m Conclusion: The incidence of post-neurosurgical AKI was 3.93% among non-ICU patients. Associated factors included vasopressor use, age ≥50 years, surgery duration ≥120 min, contrast agent use, higher systolic blood pressure, anemia, elevated serum creatinine and urea, proteinuria, higher alkaline phosphatase, and medications including propofol, mannitol, proton pump inhibitors, urapidil, and cephalosporin. Propofol association and lower PO-AKI risk across BMI categories versus BMI < 18.5 kg/m

Indexed as

Acute Kidney InjuryNeurosurgical ProceduresPostoperative ComplicationsAdultAgedFemaleHospitalizationHumansIncidenceMaleMiddle AgedRisk Factorsepidemiologyneurosurgerynon-ICU settingspostoperative acute kidney injuryrisk factors

Identifiers

PMID42626424
PMCPMC13491396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.